Showing results (1531-1540 of 1,560) with videos related to
Sort By:
Pageof 156
The Lancet. Healthy Longevity|April 5, 2026
Risk factors for early-onset and late-onset dementia: a prospective cohort studyKatherine Giorgio, John J Stephen, Maxwell Mansolf, et al.Nature Communications|June 21, 2022
A multi-ethnic polygenic risk score is associated with hypertension prevalence and progression throughout adulthoodNuzulul Kurniansyah, Matthew O Goodman, Tanika N Kelly, et al.Nature Communications|June 2, 2023
Evaluating the use of blood pressure polygenic risk scores across race/ethnic background groupsNuzulul Kurniansyah, Matthew O Goodman, Alyna T Khan, et al.Aging Cell|May 13, 2022
Integrative analysis of clinical and epigenetic biomarkers of mortalityTianxiao Huan, Steve Nguyen, Elena Colicino, et al.Human Molecular Genetics|November 29, 2022
Whole-exome sequencing study identifies four novel gene loci associated with diabetic kidney diseaseYang Pan, Xiao Sun, Xuenan Mi, et al.Nature Medicine|May 5, 2026
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individualsBrendon L Neuen, Rupert W Major, Morgan E Grams, et al.Nature Genetics|March 8, 2022
Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence dataPierrick Wainschtein, Deepti Jain, Zhili Zheng, et al.Nature Immunology|December 18, 2019
High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variationLucie Abeler-Dörner, Adam G Laing, Anna Lorenc, et al.Eclinicalmedicine|November 5, 2020
Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasetsKunihiro Matsushita, Simerjot K Jassal, Yingying Sang, et al.European Journal of Preventive Cardiology|August 16, 2022
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OPKunihiro Matsushita, Stephen Kaptoge, Steven H J Hageman, et al.Pageof 156